Timothy Daley
Stock Analyst at Wells Fargo
(2.57)
# 2,189
Out of 4,905 analysts
58
Total ratings
54.29%
Success rate
1.11%
Average return
Main Sectors:
Stocks Rated by Timothy Daley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Initiates: Equal-Weight | $47 | $48.36 | -3.47% | 1 | Dec 19, 2023 | |
| MYGN Myriad Genetics | Initiates: Equal-Weight | $20 | $4.47 | +347.43% | 1 | Dec 19, 2023 | |
| RVTY Revvity | Initiates: Equal-Weight | $95 | $93.26 | +1.87% | 1 | Dec 19, 2023 | |
| BRKR Bruker | Initiates: Equal-Weight | $72 | $40.55 | +77.56% | 1 | Dec 19, 2023 | |
| A Agilent Technologies | Maintains: Overweight | $160 → $145 | $113.99 | +27.20% | 5 | Nov 22, 2023 | |
| MTD Mettler-Toledo International | Maintains: Overweight | $1,520 → $1,300 | $1,194.85 | +8.80% | 5 | Nov 13, 2023 | |
| WAT Waters | Maintains: Equal-Weight | $305 → $285 | $287.53 | -0.88% | 5 | Nov 8, 2023 | |
| DHR Danaher | Maintains: Overweight | $285 → $247 | $190.05 | +29.97% | 3 | Oct 3, 2023 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $280 → $275 | $154.48 | +78.02% | 4 | Sep 22, 2023 | |
| LH Labcorp Holdings | Maintains: Overweight | $290 → $270 | $243.72 | +10.78% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $28 | $4.74 | +490.72% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $35 | $24.90 | +40.56% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $505 → $520 | $414.75 | +25.38% | 3 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $9 | $1.76 | +412.82% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $185 | $116.25 | +59.14% | 1 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $80 → $85 | $63.99 | +32.83% | 3 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $235 → $220 | $160.63 | +36.96% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $245 → $220 | $143.54 | +53.27% | 2 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $28 | $13.29 | +110.68% | 4 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $135 → $140 | $166.91 | -16.12% | 2 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $90 | $52.02 | +73.01% | 3 | Jan 10, 2023 |
Qiagen
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $47
Current: $48.36
Upside: -3.47%
Myriad Genetics
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $20
Current: $4.47
Upside: +347.43%
Revvity
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $95
Current: $93.26
Upside: +1.87%
Bruker
Dec 19, 2023
Initiates: Equal-Weight
Price Target: $72
Current: $40.55
Upside: +77.56%
Agilent Technologies
Nov 22, 2023
Maintains: Overweight
Price Target: $160 → $145
Current: $113.99
Upside: +27.20%
Mettler-Toledo International
Nov 13, 2023
Maintains: Overweight
Price Target: $1,520 → $1,300
Current: $1,194.85
Upside: +8.80%
Waters
Nov 8, 2023
Maintains: Equal-Weight
Price Target: $305 → $285
Current: $287.53
Upside: -0.88%
Danaher
Oct 3, 2023
Maintains: Overweight
Price Target: $285 → $247
Current: $190.05
Upside: +29.97%
Charles River Laboratories International
Sep 22, 2023
Maintains: Overweight
Price Target: $280 → $275
Current: $154.48
Upside: +78.02%
Labcorp Holdings
Aug 14, 2023
Maintains: Overweight
Price Target: $290 → $270
Current: $243.72
Upside: +10.78%
Aug 14, 2023
Maintains: Overweight
Price Target: $22 → $28
Current: $4.74
Upside: +490.72%
Jul 31, 2023
Maintains: Overweight
Price Target: $30 → $35
Current: $24.90
Upside: +40.56%
Jul 28, 2023
Maintains: Underweight
Price Target: $505 → $520
Current: $414.75
Upside: +25.38%
Jul 20, 2023
Initiates: Overweight
Price Target: $9
Current: $1.76
Upside: +412.82%
Jul 20, 2023
Initiates: Overweight
Price Target: $185
Current: $116.25
Upside: +59.14%
May 2, 2023
Maintains: Equal-Weight
Price Target: $80 → $85
Current: $63.99
Upside: +32.83%
May 1, 2023
Maintains: Equal-Weight
Price Target: $235 → $220
Current: $160.63
Upside: +36.96%
May 1, 2023
Maintains: Equal-Weight
Price Target: $245 → $220
Current: $143.54
Upside: +53.27%
Feb 8, 2023
Maintains: Overweight
Price Target: $25 → $28
Current: $13.29
Upside: +110.68%
Feb 3, 2023
Maintains: Equal-Weight
Price Target: $135 → $140
Current: $166.91
Upside: -16.12%
Jan 10, 2023
Upgrades: Equal-Weight
Price Target: $90
Current: $52.02
Upside: +73.01%